NASHVILLE, Tenn. / Jun 26, 2023 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: | HCA Healthcare, Inc. 2Q Earnings Release Call |
When: | Thursday, July 27, 2023 at 9:00 am central (10:00 am eastern) |
How: | Live Audio over the Internet: |
https://investor.hcahealthcare.com/events-and-presentations/default.aspx | |
Contact:
Frank Morgan, 615-344-2688, Vice President, Investor Relations, This email address is being protected from spambots. You need JavaScript enabled to view it.
If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$296.70 |
| Daily Change: | -1.05 -0.35 |
| Daily Volume: | 1,218,501 |
| Market Cap: | US$75.150B |
October 25, 2024 October 17, 2024 July 23, 2024 April 26, 2024 | |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
